MeiraGTx Holdings plc (MGTX)
NASDAQ: MGTX · Real-Time Price · USD
8.44
-0.22 (-2.54%)
Dec 9, 2025, 4:00 PM EST - Market closed
MeiraGTx Holdings Employees
As of December 31, 2024, MeiraGTx Holdings had 381 total employees, including 375 full-time and 6 part-time employees. The number of employees decreased by 44 or -10.35% compared to the previous year.
Employees
381
Change (1Y)
-44
Growth (1Y)
-10.35%
Revenue / Employee
$71,961
Profits / Employee
-$442,751
Market Cap
679.34M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 381 | -44 | -10.35% |
| Dec 31, 2023 | 425 | 67 | 18.72% |
| Dec 31, 2022 | 358 | 62 | 20.95% |
| Dec 31, 2021 | 296 | 77 | 35.16% |
| Dec 31, 2020 | 219 | 62 | 39.49% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
MGTX News
- 19 days ago - Graviton Bioscience to Present Selective ROCK2 Obesity Data at 8th Annual Evercore HealthCONx Conference - PRNewsWire
- 26 days ago - MeiraGTx Reports Third Quarter 2025 Financial and Operational Results - GlobeNewsWire
- 27 days ago - MeiraGTx: Latest Eli Lilly Partnership Ignites Riboswitch Technology Potential - Seeking Alpha
- 4 weeks ago - Eli Lilly signs deal for MeiraGTx's gene therapy for severe eye disease - Reuters
- 4 weeks ago - MeiraGTx Enters into Strategic Collaboration with Eli Lilly and Company to Develop and Commercialize Genetic Medicines in Ophthalmology - GlobeNewsWire
- 2 months ago - MeiraGTx Announces Two Posters at the European Society of Gene and Cell Therapy (ESGCT) 2025 Annual Congress - GlobeNewsWire
- 2 months ago - MeiraGTx: Hologen Partnership Makes Parkinson's Gene Therapy Vital - Seeking Alpha
- 4 months ago - MeiraGTx Reports Second Quarter 2025 Financial and Operational Results - GlobeNewsWire